Literature DB >> 17971790

Matrix metalloproteinase inhibition facilitates cell death in intracerebral hemorrhage in mouse.

Mark Grossetete1, Gary A Rosenberg.   

Abstract

Intracerebral hemorrhage (ICH) initiates an inflammatory response with secondary growth of hemorrhage and cell death. Matrix metalloproteinase (MMP) gelatinolytic activity is increased in ICH, and synthetic inhibitors to MMPs reduce edema and hemorrhage size. Recently, we found that tissue inhibitor of metalloproteinase-3 (TIMP-3) is elevated after ischemia and colocalizes with TUNEL (terminal deoxynucleotidyl transferase-mediated 2'-deoxyuridine 5'-triphosphate-biotin nick end-labeled)-labeled cells. Tissue inhibitor of metalloproteinase-3 promotes neuronal apoptosis in vitro by blocking the shedding of the tumor necrosis factor (TNF) superfamily of death receptors/ligands by stromelysin-1 (MMP-3). However, the effect of TIMP-3 and synthetic MMP inhibitors on cell death in ICH is unclear. Therefore, we used the collagenase-induced intracerebral hemorrhage (CIH) model in Timp-3 knockout and C57Bl/6 wild-type mice to study MMP expression, hemorrhage volume, and cell death. Real-time PCR showed an increase in Mmp-3 mRNA in CIH, but similar Mmp-2 and -9 mRNA expression levels in CIH and saline-injected mice. Protein levels of pro and cleaved MMP-3 were increased in CIH, and zymographic gelatinolytic activity of MMP-9 was elevated after CIH at 72 h, suggesting an exogenous source. Apoptosis was shown by increased caspase-3 levels at 2 and 72 h, and active caspase-8 by 2 and 24 h. The Timp-3 null mouse and wild types had similar hemorrhage sizes and TUNEL-labeled cells. Unexpectedly, the broad-spectrum MMP inhibitor BB-94 increased hemorrhage size and TUNEL-labeled cells. Our results fail to implicate TIMP-3 in apoptosis in CIH, but show that BB-94 increased apoptosis in CIH, possibly by blocking shedding of TNF death receptors and/or their ligands.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17971790     DOI: 10.1038/sj.jcbfm.9600572

Source DB:  PubMed          Journal:  J Cereb Blood Flow Metab        ISSN: 0271-678X            Impact factor:   6.200


  32 in total

1.  Efficacy of the lipid-soluble iron chelator 2,2'-dipyridyl against hemorrhagic brain injury.

Authors:  He Wu; Tao Wu; Mingchang Li; Jian Wang
Journal:  Neurobiol Dis       Date:  2011-09-10       Impact factor: 5.996

2.  Plasmalemma permeability and necrotic cell death phenotypes after intracerebral hemorrhage in mice.

Authors:  Xiaoxia Zhu; Luyang Tao; Emiri Tejima-Mandeville; Jianhua Qiu; Juyeon Park; Kent Garber; Maria Ericsson; Eng H Lo; Michael J Whalen
Journal:  Stroke       Date:  2011-11-10       Impact factor: 7.914

3.  Inhibition of neuronal ferroptosis protects hemorrhagic brain.

Authors:  Qian Li; Xiaoning Han; Xi Lan; Yufeng Gao; Jieru Wan; Frederick Durham; Tian Cheng; Jie Yang; Zhongyu Wang; Chao Jiang; Mingyao Ying; Raymond C Koehler; Brent R Stockwell; Jian Wang
Journal:  JCI Insight       Date:  2017-04-06

4.  Protective effect of melatonin upon neuropathology, striatal function, and memory ability after intracerebral hemorrhage in rats.

Authors:  Tim Lekic; Richard Hartman; Hugo Rojas; Anatol Manaenko; Wanqiu Chen; Robert Ayer; Jiping Tang; John H Zhang
Journal:  J Neurotrauma       Date:  2010-03       Impact factor: 5.269

5.  Basement membrane and stroke.

Authors:  Yao Yao
Journal:  J Cereb Blood Flow Metab       Date:  2018-09-18       Impact factor: 6.200

6.  PGE2 receptor agonist misoprostol protects brain against intracerebral hemorrhage in mice.

Authors:  He Wu; Tao Wu; Wei Hua; Xianghui Dong; Yufeng Gao; Xiaochun Zhao; Wenwu Chen; Wangsen Cao; Qingwu Yang; Jiping Qi; Jin Zhou; Jian Wang
Journal:  Neurobiol Aging       Date:  2015-01-03       Impact factor: 4.673

7.  Intracerebral hemorrhage: clinical overview and pathophysiologic concepts.

Authors:  Fred Rincon; Stephan A Mayer
Journal:  Transl Stroke Res       Date:  2012-04-21       Impact factor: 6.829

Review 8.  Tissue plasminogen activator (tPA) and matrix metalloproteinases in the pathogenesis of stroke: therapeutic strategies.

Authors:  Rao Muralikrishna Adibhatla; James F Hatcher
Journal:  CNS Neurol Disord Drug Targets       Date:  2008-06       Impact factor: 4.388

9.  Activation of TLR4-mediated NFkappaB signaling in hemorrhagic brain in rats.

Authors:  Weiyu Teng; Lishu Wang; Weishuang Xue; Chao Guan
Journal:  Mediators Inflamm       Date:  2010-01-31       Impact factor: 4.711

10.  Candesartan reduces the hemorrhage associated with delayed tissue plasminogen activator treatment in rat embolic stroke.

Authors:  Tauheed Ishrat; Bindu Pillai; Adviye Ergul; Sherif Hafez; Susan C Fagan
Journal:  Neurochem Res       Date:  2013-11-06       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.